Piccolo Lactate Dephydrogenase Test System
Nad Reduction/Nadh Oxidation, Lactate Dehydrogenase. 510(k) K051108, from Abaxis, Inc. (Union City, CA). Product code CFJ, class 2.
As of Nov 19, 2026, K051108 is an FDA 510(k) held by Abaxis, Inc., substantially equivalent on Jul 8, 2005 after 67 days, with no recalls tied to it in FDA's recall database.
- Review time: 67 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Piccolo Lactate Dehydrogenase Test System (presently contained on the Piccolo Basic Metabolic Panel Plus Disc) used with the Piccolo Point-of-Care Chemistry Analyzer is intended to be used for the in vitro quantitative determination of lactate dehydrogenase activity in heparinized plasma or serum in a clinical laboratory setting or point-of-care location.
- Modification To Synchron LX 20 Clinical Chemistry SystemK011213 · Beckman Coulter, Inc. · May 16, 2001
- Piccolo Potassium Test SystemK200865 · Abaxis, Inc. · Oct 20, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 2, 2005
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1440
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files